CEO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Samarth Kulkarni (insider trades) sold 17,275 shares of CRSP on 06/01/2020 at an average price of $64.68 a share. The total sale was $1.1 million.

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR Therapeutics AG has a market cap of $3.96 billion; its shares were traded at around $64.95 with a P/E ratio of 86.60 and P/S ratio of 13.46. GuruFocus has detected 2 severe warning signs with CRISPR Therapeutics AG. .

CEO Recent Trades:

  • CEO Samarth Kulkarni sold 17,275 shares of CRSP stock on 06/01/2020 at the average price of $64.68. The price of the stock has increased by 0.42% since.
  • CEO Samarth Kulkarni sold 15,000 shares of CRSP stock on 05/20/2020 at the average price of $65.25. The price of the stock has decreased by 0.46% since.

Directors and Officers Recent Trades:

  • President Rodger Novak sold 50,000 shares of CRSP stock on 05/26/2020 at the average price of $70.2. The price of the stock has decreased by 7.48% since.
  • Executive VP, Head of R&D Tony W Ho sold 6,700 shares of CRSP stock on 05/26/2020 at the average price of $70.13. The price of the stock has decreased by 7.39% since.
  • President Rodger Novak sold 50,000 shares of CRSP stock on 05/19/2020 at the average price of $65. The price of the stock has decreased by 0.08% since.
  • CBO & COO Lawrence Otto Klein sold 25,000 shares of CRSP stock on 05/11/2020 at the average price of $60.4. The price of the stock has increased by 7.53% since.

For the complete insider trading history of CRSP, click here

.

Comments

Please leave your comment:



Source link